- Joined
- Apr 16, 2004
- Messages
- 4,869
- Reaction score
- 5,938
I'm treating an elderly patient between 70-80 with met HER2/neu amplified breast cancer. She has been NED since 2019 when I treated her with 15 Gy x 1 fx to a left mid brain metastasis prescribed to 75% of max dose. She remained NED for the next 4 years.
Her most recent MRI shows apparent reemergence of the same brain met in the same position. It is tiny (~ 3 mm) but has been slowly growing over the last few MRI studies (every three months). Her PET scans have been clear for years and she is off treatment and has no evidence of extracranial disease.
This region is too small for functional imaging (perfusion or spectroscopy). She is not symptomatic - any suggestion? Am considering observation vs. Avastin pulse x2c vs re-treatment.
Her most recent MRI shows apparent reemergence of the same brain met in the same position. It is tiny (~ 3 mm) but has been slowly growing over the last few MRI studies (every three months). Her PET scans have been clear for years and she is off treatment and has no evidence of extracranial disease.
This region is too small for functional imaging (perfusion or spectroscopy). She is not symptomatic - any suggestion? Am considering observation vs. Avastin pulse x2c vs re-treatment.